Status:
UNKNOWN
Immunological Memory Against Pneumococcus Induced by 3 Infant PCV 13 Vaccination Schedules
Lead Sponsor:
Aghia Sophia Children's Hospital of Athens
Conditions:
Immunogenicity, Vaccine
Immunologic Memory
Eligibility:
All Genders
2-15 years
Brief Summary
The purpose of this study is to evaluate the establishment of immunological memory between the 3 different infant vaccination schedules with the 13-valent pneumococcal conjugate vaccine (PCV13) curren...
Eligibility Criteria
Inclusion
- 2-15 months of age
Exclusion
- previously recorded allergy to PCV
- intravenous immunoglobulin (IVIG) given within the previous 6 months
- primary or secondary immunodeficiency
- any chronic medical condition
Key Trial Info
Start Date :
December 12 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03405805
Start Date
December 12 2016
End Date
December 1 2019
Last Update
January 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
'Aghia Sophia' Children's Hospital
Athens, Attica, Greece, 11527